Hong Kong stocks opened in the green on Tuesday, with the benchmark Hang Seng Index gaining 0.08%, as investors kept their eyes peeled for the Reserve Bank of Australia’s policy decision and digested China's plan to accelerate stimulus rollout in the third quarter.
U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday.
Shares of bluebird bio, Inc. (NASDAQ: BLUE) shares fell sharply during Tuesday’s session after the company announced a proposed public offering of $150 million of common stock.
Pliant Therapeutics reports 12-week interim data for bexotegrast in INTEGRIS-PSC Phase 2a trial. 320 mg group met primary and secondary endpoints, showing well-tolerance and reduction in liver fibrosis.